Skip to main content
The BMJ logoLink to The BMJ
. 1996 Sep 14;313(7058):651–652. doi: 10.1136/bmj.313.7058.651

Having too much evidence (depression, suicide, and low serum cholesterol)

M Law 1
PMCID: PMC2351961  PMID: 8845726

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Downs J. R., Oster G., Santanello N. C. HMG CoA reductase inhibitors and quality of life. JAMA. 1993 Jun 23;269(24):3107–3108. doi: 10.1001/jama.269.24.3107. [DOI] [PubMed] [Google Scholar]
  2. Engelberg H. Low serum cholesterol and suicide. Lancet. 1992 Mar 21;339(8795):727–729. doi: 10.1016/0140-6736(92)90609-7. [DOI] [PubMed] [Google Scholar]
  3. Gallerani M., Manfredini R., Caracciolo S., Scapoli C., Molinari S., Fersini C. Serum cholesterol concentrations in parasuicide. BMJ. 1995 Jun 24;310(6995):1632–1636. doi: 10.1136/bmj.310.6995.1632. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Law M. R., Thompson S. G., Wald N. J. Assessing possible hazards of reducing serum cholesterol. BMJ. 1994 Feb 5;308(6925):373–379. doi: 10.1136/bmj.308.6925.373. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Lines C. Hazards of reducing cholesterol. BMJ. 1994 Aug 20;309(6953):541–541. doi: 10.1136/bmj.309.6953.541. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Magni G., Garreau M., Orofiamma B., Palminteri R. Fengabine, a new GABAmimetic agent in the treatment of depressive disorders: an overview of six double-blind studies versus tricyclics. Neuropsychobiology. 1989;20(3):126–131. doi: 10.1159/000118485. [DOI] [PubMed] [Google Scholar]
  7. Morgan R. E., Palinkas L. A., Barrett-Connor E. L., Wingard D. L. Plasma cholesterol and depressive symptoms in older men. Lancet. 1993 Jan 9;341(8837):75–79. doi: 10.1016/0140-6736(93)92556-9. [DOI] [PubMed] [Google Scholar]
  8. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) Lancet. 1994 Nov 19;344(8934):1383–1389. [PubMed] [Google Scholar]
  9. Shepherd J., Cobbe S. M., Ford I., Isles C. G., Lorimer A. R., MacFarlane P. W., McKillop J. H., Packard C. J. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med. 1995 Nov 16;333(20):1301–1307. doi: 10.1056/NEJM199511163332001. [DOI] [PubMed] [Google Scholar]
  10. Steegmans P. H., Fekkes D., Hoes A. W., Bak A. A., van der Does E., Grobbee D. E. Low serum cholesterol concentration and serotonin metabolism in men. BMJ. 1996 Jan 27;312(7025):221–221. doi: 10.1136/bmj.312.7025.221. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Wardle J., Armitage J., Collins R., Wallendszus K., Keech A., Lawson A. Randomised placebo controlled trial of effect on mood of lowering cholesterol concentration. Oxford Cholesterol Study Group. BMJ. 1996 Jul 13;313(7049):75–78. doi: 10.1136/bmj.313.7049.75. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Wysowski D. K., Gross T. P. Deaths due to accidents and violence in two recent trials of cholesterol-lowering drugs. Arch Intern Med. 1990 Oct;150(10):2169–2172. [PubMed] [Google Scholar]
  13. Zureik M., Courbon D., Ducimetière P. Serum cholesterol concentration and death from suicide in men: Paris prospective study I. BMJ. 1996 Sep 14;313(7058):649–651. doi: 10.1136/bmj.313.7058.649. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES